RecruitingNCT04806295
The Leukemia and Lymphoma Society (LLS) National Research Registry
Sponsor
Blood Cancer United
Enrollment
1,000 participants
Start Date
Jul 24, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.
Eligibility
Min Age: 21 Years
Inclusion Criteria1
- People with blood cancer, before, during, and after blood cancer treatments.
Exclusion Criteria1
- People unable or unwilling to sign informed consent.
Interventions
OTHERany/all treatments for blood cancer
Following people undergoing any/all treatments for blood cancer.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04806295
Related Trials
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
NCT069040661 location
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
NCT071481802 locations
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
NCT070529167 locations
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
NCT0611968512 locations
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
NCT064693071 location